Ignite Creation Date:
2024-05-06 @ 12:55 AM
Last Modification Date:
2024-10-26 @ 10:57 AM
Study NCT ID:
NCT01699581
Status:
TERMINATED
Last Update Posted:
2016-10-18
First Post:
2012-09-27
Brief Title:
Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant
Sponsor:
Greg Monohan
Organization:
University of Kentucky
Study Overview
Official Title:
Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant
Status:
TERMINATED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Research cancelled following interim analysis
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Nestle Impact has shown efficacy in multiple surgical trials in relation to improving hospital length of stay and infection rate 1 dose of Nestle Impact Advanced Recovery will be taken orally three times a day beginning on the morning following stem cell transplant and will continue until the day of hospital discharge
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None